morgan stanley notes to consolidated financial statements 2014 ( continued ) other regulated subsidiaries . certain other u.s . and non-u.s . subsidiaries are subject to various securities , commodities and banking regulations , and capital adequacy requirements promulgated by the regulatory and exchange authorities of the countries in which they operate . these subsidiaries have consistently operated with capital in excess of their local capital adequacy requirements . morgan stanley derivative products inc . ( 201cmsdp 201d ) , a derivative products subsidiary rated a3 by moody 2019s and aa- by s&p , maintains certain operating restrictions that have been reviewed by moody 2019s and s&p . msdp is operated such that creditors of the company should not expect to have any claims on the assets of msdp , unless and until the obligations to its own creditors are satisfied in full . creditors of msdp should not expect to have any claims on the assets of the company or any of its affiliates , other than the respective assets of msdp . the regulatory capital requirements referred to above , and certain covenants contained in various agreements governing indebtedness of the company , may restrict the company 2019s ability to withdraw capital from its subsidiaries . at december 31 , 2014 and december 31 , 2013 , approximately $ 31.8 billion and $ 21.9 billion , respectively , of net assets of consolidated subsidiaries may be restricted as to the payment of cash dividends and advances to the parent company . 15 . total equity morgan stanley shareholders 2019 equity . common stock . changes in shares of common stock outstanding for 2014 and 2013 were as follows ( share data in millions ) : .
what is the net change in shares of common stock outstanding from 2013 to 2014 in millions?
( 1 ) treasury stock purchases include repurchases of common stock for employee tax withholding . ( 2 ) other includes net shares issued to and forfeited from employee stock trusts and issued for rsu conversions . treasury shares . at december 31 , 2014 , the company had approximately $ 0.3 billion remaining under its current share repurchase program . the share repurchase program is for capital management purposes and considers , among other things , business segment capital needs as well as equity-based compensation and benefit plan requirements . share repurchases under the company 2019s existing authorized program will be exercised from time to time at prices the company deems appropriate subject to various factors , including the company 2019s capital position and market conditions . the share repurchases may be effected through open market purchases or privately negotiated transactions , including through rule 10b5-1 plans , and may be suspended at any time . share repurchases by the company are subject to regulatory approval ( see 201cmarket for registrant 2019s common equity , related stockholder matters and issuer purchases of equity securities 201d in part ii , item 5 ) . in march 2014 , the company received no objection from the federal reserve to the company 2019s 2014 capital plan , which included a share repurchase of up to $ 1 billion of the company 2019s outstanding common stock beginning in the second quarter of 2014 through the end of the first quarter of 2015 as well as an increase in the company 2019s quarterly common stock dividend to $ 0.10 per share from $ 0.05 per share , beginning with the dividend declared on april 17 , 2014 . the cash dividends declared on the company 2019s outstanding preferred stock .